The studies of rare genetic defects, the preliminary results of population-
based studies, being validated by the experimental immunocompromised animal
models and the current observations accumulated in immunocompromised patie
nts with mycobacterial diseases provide us with insights into the importanc
e of the macrophage activation pathway in controlling human infection with
pathogenic and non pathogenic intracellular multiplying mycobacteria.
Initial cytokine production by infected macrophages and/or dendritic cells
could be crucial in the overall regulation of self cure, acquired protectio
n or immunopathological sequelae expressing the disease. Knowledge of molec
ular and generic cross-talks between phagocytic and specialized antigen pre
senting cells and different mycobacterial products associated with persiste
nce or replication of the intracellular bacteria, could provide further inf
ormations on the global immune regulation of the early host responses to in
fection and the following events. It seems likely that the development of m
ycobacterial infections in humans will turn out to be as much dependent on
the genetic make up of the host as or the virulence of the bacteria.